BACKGROUND: Anthrax lethal toxin (LT), secreted by Bacillus anthracis, causes severe cardiac dysfunction by unknown mechanisms. LT specifically cleaves the docking domains of MAPKK (MEKs); thus, we hypothesized that LT directly impairs cardiac function through dysregulation of MAPK signaling mechanisms. METHODS AND RESULTS: In a time-course study of LT toxicity, echocardiography revealed acute diastolic heart failure accompanied by pulmonary regurgitation and left atrial dilation in adult Sprague-Dawley rats at time points corresponding to dysregulated JNK, phospholamban (PLB) and protein phosphatase 2A (PP2A) myocardial signaling. Using isolated rat ventricular myocytes, we identified the MEK7-JNK1-PP2A-PLB signaling axis to be important for regulation of intracellular calcium (Ca(2+)(i)) handling, PP2A activation and targeting of PP2A-B56α to Ca(2+)(i) handling proteins, such as PLB. Through a combination of gain-of-function and loss-of-function studies, we demonstrated that over-expression of MEK7 protects against LT-induced PP2A activation and Ca(2+)(i) dysregulation through activation of JNK1. Moreover, targeted phosphorylation of PLB-Thr(17) by Akt improved sarcoplasmic reticulum Ca(2+)(i) release and reuptake during LT toxicity. Co-immunoprecipitation experiments further revealed the pivotal role of MEK7-JNK-Akt complex formation for phosphorylation of PLB-Thr(17) during acute LT toxicity. CONCLUSIONS: Our findings support a cardiogenic mechanism of LT-induced diastolic dysfunction, by which LT disrupts JNK1 signaling and results in Ca(2+)(i) dysregulation through diminished phosphorylation of PLB by Akt and increased dephosphorylation of PLB by PP2A. Integration of the MEK7-JNK1 signaling module with Akt represents an important stress-activated signalosome that may confer protection to sustain cardiac contractility and maintain normal levels of Ca(2+)(i) through PLB-T(17) phosphorylation.
BACKGROUND:Anthrax lethal toxin (LT), secreted by Bacillus anthracis, causes severe cardiac dysfunction by unknown mechanisms. LT specifically cleaves the docking domains of MAPKK (MEKs); thus, we hypothesized that LT directly impairs cardiac function through dysregulation of MAPK signaling mechanisms. METHODS AND RESULTS: In a time-course study of LTtoxicity, echocardiography revealed acute diastolic heart failure accompanied by pulmonary regurgitation and left atrial dilation in adult Sprague-Dawley rats at time points corresponding to dysregulated JNK, phospholamban (PLB) and protein phosphatase 2A (PP2A) myocardial signaling. Using isolated rat ventricular myocytes, we identified the MEK7-JNK1-PP2A-PLB signaling axis to be important for regulation of intracellular calcium (Ca(2+)(i)) handling, PP2A activation and targeting of PP2A-B56α to Ca(2+)(i) handling proteins, such as PLB. Through a combination of gain-of-function and loss-of-function studies, we demonstrated that over-expression of MEK7 protects against LT-induced PP2A activation and Ca(2+)(i) dysregulation through activation of JNK1. Moreover, targeted phosphorylation of PLB-Thr(17) by Akt improved sarcoplasmic reticulum Ca(2+)(i) release and reuptake during LTtoxicity. Co-immunoprecipitation experiments further revealed the pivotal role of MEK7-JNK-Akt complex formation for phosphorylation of PLB-Thr(17) during acute LT toxicity. CONCLUSIONS: Our findings support a cardiogenic mechanism of LT-induced diastolic dysfunction, by which LT disrupts JNK1 signaling and results in Ca(2+)(i) dysregulation through diminished phosphorylation of PLB by Akt and increased dephosphorylation of PLB by PP2A. Integration of the MEK7-JNK1 signaling module with Akt represents an important stress-activated signalosome that may confer protection to sustain cardiac contractility and maintain normal levels of Ca(2+)(i) through PLB-T(17) phosphorylation.
Authors: Benjamin E Turk; Thiang Yian Wong; Robert Schwarzenbacher; Emily T Jarrell; Stephen H Leppla; R John Collier; Robert C Liddington; Lewis C Cantley Journal: Nat Struct Mol Biol Date: 2003-12-29 Impact factor: 15.369
Authors: L Borio; D Frank; V Mani; C Chiriboga; M Pollanen; M Ripple; S Ali; C DiAngelo; J Lee; J Arden; J Titus; D Fowler; T O'Toole; H Masur; J Bartlett; T Inglesby Journal: JAMA Date: 2001-11-28 Impact factor: 56.272
Authors: Inês Falcão-Pires; Nazha Hamdani; Attila Borbély; Cristina Gavina; Casper G Schalkwijk; Jolanda van der Velden; Loek van Heerebeek; Ger J M Stienen; Hans W M Niessen; Adelino F Leite-Moreira; Walter J Paulus Journal: Circulation Date: 2011-08-15 Impact factor: 29.690
Authors: Bushra Mina; J P Dym; Frank Kuepper; Raymond Tso; Carmina Arrastia; Irina Kaplounova; Hasan Faraj; Agnieszka Kwapniewski; Christopher M Krol; Mayer Grosser; Jeffrey Glick; Steven Fochios; Athena Remolina; Ljiljana Vasovic; Jeffrey Moses; Thomas Robin; Maria DeVita; Michael L Tapper Journal: JAMA Date: 2002-02-20 Impact factor: 56.272
Authors: William S Lawrence; Jeffrey R Marshall; Diana L Zavala; Lori E Weaver; Wallace B Baze; Scott T Moen; Elbert B Whorton; Randy L Gourley; Johnny W Peterson Journal: Toxins (Basel) Date: 2011-06-23 Impact factor: 4.546
Authors: Uwe Kirchhefer; Christiane Brekle; John Eskandar; Gunnar Isensee; Dana Kučerová; Frank U Müller; Florence Pinet; Jan S Schulte; Matthias D Seidl; Peter Boknik Journal: J Biol Chem Date: 2014-10-15 Impact factor: 5.157
Authors: David E Dostal; Hao Feng; Damir Nizamutdinov; Honey B Golden; Syeda H Afroze; Joseph D Dostal; John C Jacob; Donald M Foster; Carl Tong; Shannon Glaser; Fnu Gerilechaogetu Journal: J Clin Exp Cardiolog Date: 2014-06-05